A hometown newspaper with a local office, local owners & lots of local news
A hometown newspaper with a local office, local owners & lots of local news
The respiratory syncytial virus (RSV) is a common virus that can cause serious respiratory illness, especially in older adults. In recent years, advancements in medical research have led to the development of a new one-time RSV vaccine, which offers much-needed protection for adults age 75 and older, as well as for those age 60 to 74 who are at a higher risk of severe RSV.
According to the Centers for Disease Control and Prevention and the World Health Organization, this vaccine is a key step in preventing severe RSV-related complications, including pneumonia and bronchitis.
RSV infections are most often associated with young children, but they can have a significant impact on older adults as well. As we age, our immune systems weaken, making it harder to fight off infections like RSV. The CDC estimates that each year, RSV leads to over 100,000
hospitalizations and 6,000-10,000 deaths among adults 65 and older in the United States. The new vaccine aims to reduce these numbers by offering targeted protection.
The CDC recommends that all adults age 75 and older receive the RSV vaccine due to their heightened risk of severe illness. Additionally, adults age 60 to 74 who have underlying health conditions, such as chronic heart or lung disease, diabetes or weakened immune systems, should also consider getting vaccinated. The vaccine has been shown to reduce the risk of severe illness and hospitalization. It is administered as a single dose and has been tested for both safety and efficacy in clinical trials. The vaccine can be given during routine visits with your healthcare provider or at many local pharmacies.
WHO emphasizes the importance of immunization as a preventive measure for vulnerable populations, including older adults. Vaccination not only protects the individual but also helps reduce the spread of RSV within the community, especially to other high-risk individuals like young children and those with compromised immune systems.
It is crucial for older adults and their families to discuss the benefits of the RSV vaccine with their healthcare providers or pharmacists to make informed decisions about vaccination.
Preventing serious RSV infections can help maintain independence, reduce hospital stays, and improve overall quality of life.
Robert Johnson is a local hospital/infusion pharmacist in Moose Lake, committed to providing accurate and helpful information to the community. Contact him at [email protected].
